BioSig Technologies Issues Shareholder Letter for 2017
December 21, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
November 14, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors
November 10, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 10, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28
November 08, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Partners with Sherpa Technology Group
November 02, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 02, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System
October 26, 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
October 24, 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
October 19, 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference
October 13, 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer
October 11, 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...